Journal of Clinical Investigation · 2005 · 70 citations · 53 references
Neurologic impairment in HIV-1-associated dementia (HAD) and other neuroinflammatory diseases correlates with injury to dendrites and synapses, but how such injury occurs is not known. We hypothesized that neuroinflammation makes dendrites susceptible to excitotoxic injury following synaptic activity. We report that platelet-activating factor, an inflammatory phospholipid that mediates synaptic plasticity and neurotoxicity and is dramatically elevated in the brain during HAD, promotes dendrite injury following elevated synaptic activity and can replicate HIV-1-associated dendritic pathology. In hippocampal slices exposed to a stable platelet-activating factor analogue, tetanic stimulation that normally induces long-term synaptic potentiation instead promoted development of calcium- and caspase-dependent dendritic beading. Chemical preconditioning with diazoxide, a mitochondrial ATP-sensitive potassium channel agonist, prevented dendritic beading and restored long-term potentiation. In contrast to models invoking excessive glutamate release, these results suggest that physiologic synaptic activity may trigger excitotoxic dendritic injury during chronic neuroinflammation. Furthermore, preconditioning may represent a novel therapeutic strategy for preventing excitotoxic injury while preserving physiologic plasticity.
53
HS Chen, JW Pellegrini, SK Aggarwal et al. · Journal of Neuroscience · 1992 · 627 citations · Full text
Pharmacotherapy, Nmda Receptor-mediated Neurotoxicity, Social Sciences +16
Secretion of Neurotoxins by Mononuclear Phagocytes Infected with HIV-1
Dana Giulian, Ken Vaca, C A Noonan · Science · 1990 · 622 citations
P Genis, Marti Jett, Edward W. Bernton et al. · The Journal of Experimental Medicine · 1992 · 533 citations · Full text